Early Indicator Stock on the Move for Wednesday, February 14, 2007: Earnings Announcement Shows Continued Growth and Profitability!
Market Wire, February, 2007
TheSUBWAY.com names the following stocks to its Stock Alert List: Renhuang Pharmaceuticals, Inc. (OTCBB: RHGP), Poniard Pharmaceuticals, Inc. (NASDAQ: PARD), Syntax-Brillian Corporation (NASDAQ: BRLC), Xyratex Ltd. (NASDAQ: XRTX).
Renhuang Pharmaceuticals, Inc. (OTCBB: RHGP), a leading provider of natural health care products in the People's Republic of China (PRC), filed its first 10K since it went public in September 2006 and announced its results for the transition period of May 1 to October 31, 2006.
Related Results
Basic earnings per common share for the six month period were $0.125 per share. Revenues for the six month period from May 1 to October 31, 2006 remained strong, reaching $12.25 million compared to $11.72 million for the same period of last year. Overall, the Company is very optimistic about growing its earnings and revenues over time. With several new products recently launched and its traditional products in strong demand, the Company is confident that earnings and revenues will grow continuously.
"We are very pleased to see our earnings grow significantly year over year, with a net income of $4.4 million generated in this first six month period since we became a public company," said Mr. Li, Shaoming. "In the light of the current results, we believe in a continued growth and profitability given our highly sought after products, strong R&D program, superior manufacturing capability, and large distribution network. We expect to continue to deliver high growth in our business and we are committed to looking for every opportunity to create value for our shareholders. For the fiscal year 2007 we expect revenues to be between $ 35 to $ 40 million and net profits to be between $ 10 to $ 12 million."
Other stocks highlighted include Poniard Pharmaceuticals, Inc. (NASDAQ: PARD): Stock Pick List, up 1% on 2 million shares, Syntax-Brillian Corporation (NASDAQ: BRLC): Stock Pick List, up 1% on 1 million shares, Xyratex Ltd. (NASDAQ: XRTX): Stock Pick List, down 1% on 1 million shares.
"The real estate market continues to be the wild card in the broader economy, and even has stock market investors worried as well. Indeed, some markets saw price appreciation rates of as much as 50%, while the national average was better than 10%. But as home price trends tend to lag behind sales trends by about nine to 12 months, many are predicting home prices will be weakest in 2008 and perhaps even into 2009." More is available at: http://www.thesubway.com .
TheSUBWAY.com's Daily Stock Updates:
TheSUBWAY.com, a leader in corporate communications and finance, highlights stocks that are in the news, have traded high volume, or experienced a large change in price in recent sessions. The aforementioned commentary is not meant to be indicative of a "long term" view of any of the companies listed. For more go to http://www.thesubway.com .
All material herein was prepared by Capital Research Group, Inc. (CRG) based upon information believed to be reliable. The information contained herein is not guaranteed by CRG to be accurate, and should not be considered to be all-inclusive. The companies that are discussed in this opinion have not approved the statements made in this opinion. This opinion contains forward-looking statements that involve risks and uncertainties. This material is for informational purposes only and should not be construed as an offer or solicitation of an offer to buy or sell securities. CRG is not a licensed broker, broker dealer, market maker, investment banker, investment advisor, analyst or underwriter. Please consult a broker before purchasing or selling any securities viewed on http://www.thesubway.com or mentioned herein. CRG has been compensated by third party shareholders or with cash from the company on behalf of one or more of the companies mentioned in this opinion. CRG has been compensated fifty five thousand shares for RHGP. CRG has also purchased five thousand shares in the open market. CRG intends to sell its shares. CRG has sold approximately zero RHGP shares to date. CRG may sell its shares for less than the target price given in this opinion. In addition to any compensation mentioned above, additional compensation can be equal to ten percent of any newly issued or registered securities of the profiled companies. CRG's affiliates, officers, directors and employees intend to buy and sell additional shares in any company mentioned within and may profit in the event those shares rise in value. CRG will not advise as to when it decides to sell and does not and will not offer any opinion as to when others should sell; each investor must make that decision based on his or her judgment of the market.
CONTACT: Capital Research Group Charles Tamburello 954-217-8555 www.TheSUBWAY.com
- 5 Rules for Immediate Annuities
- Death in the Family: 12 Things to Do Now
- Dumbest Things You Do With Your Money
- 6 Online Networking Mistakes to Avoid
- 401(k) Mistakes to Avoid
- 5 Economic Scenarios to Keep You Up at Night
- The Real ‘Best Places to Retire’
- Best Credit Cards for You
- 12 Tough Questions to Ask Your Parents
- The Real ‘Best Colleges’
- Home Buyer Tax Credit: How to Cash In
- Why You Shouldn't Bash Cash
- 8 Phony 'Bargains' and Better Alternatives
- Danger: 3 Debit Card Scams to Avoid
- 6 Myths About Gas Mileage
- 29 Fees We Hate Most
- Quick and Easy Ways to Boost Returns
- Best Stocks to Buy Now
- Lower Your Taxes: 10 Moves to Make Now
- New Jobs: 8 Lessons from Real-Life Career Switchers
- The New Job Market: Who Wins and Who Loses?
- Health Care Reform's Public Option: Everything You Need to Know
- Volunteer Work When Unemployed: Should You Work for Free?
- Whose Recovery Is This?
- Long-Term-Care Insurance: 4 Biggest Risks to Avoid
Most Recent Business Articles
- Psyadon Pharmaceuticals, Inc. Announces Regulatory Milestones and the Initiation of a Clinical Trial of Ecopipam in Lesch-Nyhan Disease
- Emergence of “Femtomedicine” - New Frontier of Biomed Sciences - Reported at First Global Congress on Nano Medicine
- Research and Markets: Ethiopia Power Market Outlook to 2020
- Research and Markets: Orphan Drugs in Asia-Pacific: from Designation to Pricing, Funding & Market Access
- Research and Markets: Now You See It - TV Program Sponsorship & Product Placement in China
Most Recent Business Publications
Most Popular Business Articles
- 7 tips for effective listening: productive listening does not occur naturally. It requires hard work and practice - Back To Basics - effective listening is a crucial skill for internal auditors
- FHM Features Anna Benson, Baseball's Hottest Wife
- Building a DNA database: the federal government has just enacted two bills related to DNA. The first would drive the collection of DNA from all infants. The second would attempt to prevent the DNA that is collected from being misused
- America's most wanted j-o-b-s - 10 hottest employment opportunities
- Developmental sequence in small groups


